BXMPY (Beximco Pharmaceuticals) Other Long Term Assets: $0.44 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Beximco Pharmaceuticals Other Long Term Assets?

Beximco Pharmaceuticals BXMPY 92 Other Long Term Assets is $0.44 Mil as of Mar. 2026. GuruFocus rates BXMPY with a GF Score™ of 92/100. The stock has 6 warning signs investors should review.

Beximco Pharmaceuticals's other long-term assets for the quarter that ended in Mar. 2026 was $0.44 Mil.

Beximco Pharmaceuticals's quarterly other long-term assets declined from Sep. 2025 ($0.46 Mil) to Dec. 2025 ($0.41 Mil) but then increased from Dec. 2025 ($0.41 Mil) to Mar. 2026 ($0.44 Mil).

Beximco Pharmaceuticals's annual other long-term assets increased from Jun. 2023 ($0.63 Mil) to Jun. 2024 ($0.66 Mil) but then declined from Jun. 2024 ($0.66 Mil) to Jun. 2025 ($0.53 Mil).

Beximco Pharmaceuticals Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Beximco Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals Other Long Term Assets Chart

Beximco Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 6.34 0.63 0.66 0.53

Beximco Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.53 0.46 0.41 0.44

Beximco Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $0.44 Mil mean?
Beximco Pharmaceuticals (BXMPY) has a Other Long Term Assets of $0.44 Mil as of Mar. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Beximco Pharmaceuticals and its competitors.
Is Beximco Pharmaceuticals' Other Long Term Assets too high?
Beximco Pharmaceuticals' current Other Long Term Assets is $0.44 Mil. Overall, Beximco Pharmaceuticals has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Other Long Term Assets compare to ZTS and UTHR?
Beximco Pharmaceuticals' Other Long Term Assets of $0.44 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Drug Manufacturers company?
A good Other Long Term Assets depends on the Drug Manufacturers industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Beximco Pharmaceuticals and its competitors. Beximco Pharmaceuticals's current Other Long Term Assets is $0.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (BXMPY) has a current Other Long Term Assets of $0.44 Mil. The current Other Long Term Assets is $0.44 Mil. Beximco Pharmaceuticals' overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Beximco Pharmaceuticals (BXMPY), the current Other Long Term Assets is $0.44 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beximco Pharmaceuticals Business Description

Address 19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.